Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
Clinical trial NCT00216060 · TERMINATED
Trial details
- NCT number
- NCT00216060
- Sponsor
- Christopher Sweeney, MBBS
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2008-02-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.